FAB Block vs. Placebo for Hip Arthroplasty Patients
Launched by WOMEN'S COLLEGE HOSPITAL · Mar 6, 2020
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new technique called the femoral articular branch block (FAB) to help reduce pain after hip replacement surgery, also known as hip arthroplasty. The goal is to see if this method can lower the need for strong pain medications (opioids) and improve how well patients recover after surgery. In this trial, half of the participants will receive the FAB block, while the other half will receive a placebo, which is a treatment that looks the same but has no active ingredients. By comparing both groups, researchers hope to determine how effective the FAB block is in managing pain.
To participate in this study, you need to be between 18 and 60 years old, have a body mass index (BMI) of 35 or less, and be generally healthy (ASA I-III). However, if you have certain medical conditions, such as nerve damage in the relevant areas, infections, or allergies to local anesthetics, you might not be eligible. Participants can expect to be randomly assigned to either the FAB block or the placebo group, and they will be monitored for pain levels and recovery experiences after their surgery. It's important to note that the trial is not yet recruiting participants, but it aims to gather valuable information that could help improve pain management for future hip surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I-III patients
- • Ages 18-60yrs
- • BMI ≤ 35 kg/m2
- Exclusion Criteria:
- • Preexisting neurological deficits or peripheral neuropathy in the distribution of femoral, obturator, or lateral cutaneous nerves
- • Local infection
- • Contra-indication to regional anesthesia e.g. bleeding diathesis, coagulopathy
- • Chronic pain disorders
- • History of use of over 30mg oxycodone or equivalent per day
- • Contraindication to a component of multi-modal analgesia
- • Allergy to local anesthetics
- • History of significant psychiatric conditions that may affect patient assessment
- • Pregnancy
- • Inability to provide informed consent
- • Patient refusal of FAB
- • Revision arthroscopy surgeries
About Women's College Hospital
Women's College Hospital (WCH) is a leading academic health sciences center in Toronto, dedicated to advancing women's health through innovative research, education, and exceptional patient care. As a progressive institution, WCH focuses on addressing the unique health needs of women, fostering groundbreaking clinical trials that contribute to the understanding and treatment of various health conditions. With a commitment to collaboration, WCH partners with various stakeholders, including academic institutions and healthcare organizations, to enhance the quality of care and improve health outcomes for women. Through its robust research programs, Women's College Hospital is at the forefront of shaping future healthcare practices and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Richard Brull, MD
Principal Investigator
Women's College Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials